glp-1 news today nov 2025 weight loss drug november Weight-Loss Drugs Could Address a Range of Addictions GLP-1 Trends: Access & Shortages, – Novo Nordisk outgoing CEO blames

Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice

Studies have shown that the expression of the VRK2 gene is linked to depression risk, with its regulatory mechanisms demonstrating significant spatial specificity in affected individuals [311]

A recent survey found that while roughly two-thirds of employers are covering or considering GLP-1s, many are also prioritizing vendor oversight, data transparency, and integrated support models

This includes Novo Nordisk GLP-1 products such as semaglutide and liraglutide that have been on the market for more than 13 years